$701 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 131 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 55.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITRN | Sell | ITURAN LOCATION AND CONTROL | $8,266,000 | -13.2% | 229,283 | -24.7% | 1.18% | -27.2% |
| ORBK | Sell | ORBOTECH LTDord | $7,397,000 | +6.1% | 175,243 | -18.0% | 1.06% | -11.0% |
| FGEN | Sell | FIBROGEN INC | $6,982,000 | +30.5% | 129,779 | -21.7% | 1.00% | +9.6% |
| IMMU | Sell | IMMUNOMEDICS INC | $6,291,000 | +29.5% | 450,000 | -18.2% | 0.90% | +8.8% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $5,760,000 | +3.5% | 1,000,000 | -9.1% | 0.82% | -13.1% |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $5,110,000 | +4.6% | 1,400,000 | -36.4% | 0.73% | -12.2% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $4,982,000 | -15.0% | 405,000 | -42.1% | 0.71% | -28.5% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $4,693,000 | +4.6% | 129,474 | -19.9% | 0.67% | -12.1% |
| RTRX | Sell | RETROPHIN INC | $4,334,000 | +6.9% | 174,131 | -16.7% | 0.62% | -10.3% |
| Sell | TEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0 | $4,096,000 | -52.6% | 11,885 | -18.2% | 0.58% | -60.2% | |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $3,943,000 | -3.9% | 127,000 | -15.3% | 0.56% | -19.2% |
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $3,530,000 | +13.2% | 221,430 | -14.1% | 0.50% | -4.9% |
| UNP | Sell | UNION PAC CORP | $3,149,000 | -31.8% | 27,156 | -36.0% | 0.45% | -42.8% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $2,907,000 | -29.8% | 248,472 | -16.1% | 0.42% | -41.0% |
| SEDG | Sell | SOLAREDGE TECHNOLOGIES INC | $2,912,000 | -14.9% | 102,003 | -40.4% | 0.42% | -28.6% |
| SBPH | Sell | SPRING BK PHARMACEUTICALS IN | $2,685,000 | +13.3% | 159,417 | -8.9% | 0.38% | -5.0% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $2,661,000 | -7.3% | 95,000 | -36.7% | 0.38% | -22.1% |
| ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $2,445,000 | -28.5% | 115,500 | -40.9% | 0.35% | -39.9% |
| NOMD | Sell | NOMAD FOODS LTD | $2,428,000 | -35.8% | 166,662 | -37.8% | 0.35% | -46.2% |
| TXMD | Sell | THERAPEUTICSMD INC | $2,010,000 | -34.2% | 380,000 | -34.5% | 0.29% | -44.7% |
| DOVA | Sell | DOVA PHARMACEUTICALS INC | $1,901,000 | -10.2% | 78,284 | -17.6% | 0.27% | -24.7% |
| SNA | Sell | SNAP ON INC | $1,087,000 | -56.5% | 7,292 | -53.8% | 0.16% | -63.4% |
| VSAR | Sell | VERSARTIS INC | $802,000 | -87.8% | 327,524 | -13.2% | 0.11% | -89.8% |
| CSTE | Sell | CAESARSTONE LTD | $531,000 | -87.7% | 17,833 | -85.5% | 0.08% | -89.6% |
| TJX | Sell | TJX COS INC NEW | $428,000 | -76.0% | 5,800 | -76.5% | 0.06% | -79.9% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $217,000 | -58.4% | 111,762 | -42.2% | 0.03% | -65.2% |
| PTN | Exit | PALATIN TECHNOLOGIES INC | $0 | – | -470,983 | -100.0% | -0.03% | – |
| NVMI | Exit | NOVA MEASURING INSTRUMENTS L | $0 | – | -13,844 | -100.0% | -0.05% | – |
| CAMT | Exit | CAMTEK LTDord | $0 | – | -99,035 | -100.0% | -0.08% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -35,000 | -100.0% | -0.18% | – |
| Exit | ISHARES TRcall | $0 | – | -100 | -100.0% | -0.24% | – | |
| WAB | Exit | WABTEC CORP | $0 | – | -16,600 | -100.0% | -0.26% | – |
| FLEX | Exit | FLEX LTDord | $0 | – | -94,500 | -100.0% | -0.26% | – |
| TSEM | Exit | TOWER SEMICONDUCTOR LTD | $0 | – | -67,155 | -100.0% | -0.27% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -75,000 | -100.0% | -0.28% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -1,331,421 | -100.0% | -0.31% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -36,000 | -100.0% | -0.32% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -11,688 | -100.0% | -0.35% | – |
| Exit | O REILLY AUTOMOTIVE INC NEWcall | $0 | – | -100 | -100.0% | -0.35% | – | |
| Exit | NEURODERM LTD | $0 | – | -74,500 | -100.0% | -0.38% | – | |
| LRCX | Exit | LAM RESEARCH CORP | $0 | – | -16,860 | -100.0% | -0.40% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -240,000 | -100.0% | -0.46% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -833,633 | -100.0% | -0.47% | – |
| Exit | ADVANCE AUTO PARTS INCcall | $0 | – | -250 | -100.0% | -0.48% | – | |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.50% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -90,167 | -100.0% | -0.55% | – |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -320,796 | -100.0% | -0.61% | – |
| Exit | TEVA PHARMACEUTICAL INDS LTDput | $0 | – | -1,120 | -100.0% | -0.61% | – | |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -30,000 | -100.0% | -0.62% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.68% | – |
| Exit | MYLAN N Vcall | $0 | – | -1,500 | -100.0% | -0.99% | – | |
| Exit | CELGENE CORPcall | $0 | – | -500 | -100.0% | -1.15% | – | |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -2.07% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -248,000 | -100.0% | -2.35% | – |
| Exit | BIOGEN INCcall | $0 | – | -500 | -100.0% | -2.46% | – | |
| NVS | Exit | NOVARTIS A Gsponsored adr | $0 | – | -200,000 | -100.0% | -2.71% | – |
| Exit | POWERSHARES QQQ TRUSTput | $0 | – | -1,200 | -100.0% | -2.92% | – | |
| Exit | SPDR SERIES TRUSTput | $0 | – | -5,566 | -100.0% | -7.39% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-11-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.